Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease
This study deciphers the lipid signature in DKD progression, and suggests the Lipid9-SCB panel as a promising tool for early DKD detection in DM patients.
Authors
- Cen Xie (ORCID: https://orcid.org/0000-0002-4574-8456)
- Yifei Zhong (ORCID: https://orcid.org/0000-0002-2462-3064)
- Y. N. Wang
- Cuina Li
- Zixuan Zhang (ORCID: https://orcid.org/0000-0001-5020-7606)
- Jiaqi Li (ORCID: https://orcid.org/0000-0001-9038-9010)
- Xueling Li (ORCID: https://orcid.org/0000-0003-3975-6860)
- Xiaozhen Guo (ORCID: https://orcid.org/0000-0002-2358-1309)
- Yameng Liu (ORCID: https://orcid.org/0000-0002-5991-3889)
- Kanglong Wang (ORCID: https://orcid.org/0009-0005-7676-5522)
- Yan Cao (ORCID: https://orcid.org/0009-0009-6850-4516)
- Yangyang Wang (ORCID: https://orcid.org/0009-0003-6047-0282)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Chinese Academy of Sciences (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Institute of Materia Medica (CN)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- Metabolism Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.metop.2025.100354
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71